Lung Cancer News

Two novel blood assays demonstrated efficacy in detecting various cancer types at different disease stages, according to results of two studies presented at ASCO Breakthrough in Bangkok.

GO2 Foundation for Lung Cancer presented several awards at its 14th annual Simply the Best Dinner and Gala.

The FDA office that reviews applications for cancer therapies has been renamed and reorganized.

NEW ORLEANS — When compared with existing technologies, robotic bronchoscopy increased the ability to localize and successfully puncture small peripheral pulmonary nodules, researchers reported.

Lung Cancer Awareness Month — observed every November — is intended to educate the public about the potential causes and risk factors of the disease.

NEW ORLEANS — A genomic sequencing classifier can help identify the probability of malignancy for patients with lung nodules and improve the sensitivity of bronchoscopy overall, according to a study presented at the CHEST Annual Meeting.

The addition of durvalumab to chemotherapy extended PFS for patients with previously untreated stage IV non-small cell lung cancer, according to topline data from the randomized phase 3 POSEIDON trial.

The addition of nivolumab and low-dose ipilimumab to first-line chemotherapy significantly extended OS for patients with advanced non-small cell lung cancer, according to results of a prespecified interim analysis from the randomized phase 3 CheckMate -9LA trial.

Smoking any type of cigarette is associated with an increased risk for lung cancer incidence and death, but unfiltered cigarettes pose the greatest risk, according to a study published in JAMA Internal Medicine.

Healio Pulmonology has you covered. The Editors have compiled a list of the most popular articles posted on Healio Pulmonology in September.